Huntington's disease

UniQure Stock Doubles After Striking A Deal With The FDA For Huntington's Drug
Investors Business Daily
Tue, 12/10/24 - 11:31 am
uniQure
FDA
Huntington's disease
AMT-130
Novartis wagers billions of dollars on PTC Huntington’s drug
BioPharma Dive
Mon, 12/2/24 - 11:26 am
Novartis
PTC Therapeutics
Huntington's disease
PTC518
Sage wilts as Huntington's prospect flunks trial
Pharmaphorum
Wed, 11/20/24 - 11:25 am
SAGE Therapeutics
clinical trials
dalzanemdor
Huntington's disease
Goodbye Wave: Takeda axes Huntington’s pact, freeing partner to pursue fresh pact
Fierce Biotech
Wed, 10/16/24 - 09:54 am
Takeda
Wave Life Sciences
Huntington's disease
Huntington’s disease R&D is regaining ground after several disappointments
Pharma Voice
Mon, 09/9/24 - 10:44 am
Huntington's disease
uniQure
Prilenia Therapeutics
Wave
Roche
Ionis Pharmaceuticals
Vico Therapeutics
UniQure Wins First FDA RMAT in Huntington’s Disease After Strong Phase I/II Data
BioSpace
Tue, 07/9/24 - 11:51 am
uniQure
AMT-130
Huntington's disease
clinical trials
Wave, with new data, plots path forward for Huntington’s drug
BioPharma Dive
Tue, 06/25/24 - 09:08 pm
Wave Life Sciences
Huntington's disease
antisense
WVE-003
PTC Reports Positive Phase II Huntington’s Data, FDA Lifts Partial Clinical Hold
BioSpace
Thu, 06/20/24 - 06:00 pm
PTC Therapeutics
Huntington's disease
PTC518
clinical trials
Sage’s Dalzanemdor Shows Effect in Huntington’s Study, Analysts Say Results ‘Underwhelming’
BioSpace
Tue, 06/11/24 - 10:51 pm
SAGE Therapeutics
dalzanemdor
clinical trials
Huntington's disease
Neurocrine Biosciences' Huntington's disease drug gets FDA approval
Reuters
Tue, 04/30/24 - 06:27 pm
Neurocrine Biosciences
FDA
Ingrezza
Huntington's disease
6 Neuro Data Readouts to Watch in the First Half of 2024
BioSpace
Mon, 01/22/24 - 11:53 am
neurodegenerative disease
clinical trials
ALS
major depressive disorder
Huntington's disease
Sanofi
Denali Therapeutics
Intra-Cellular Therapies
lumateperone
Annexon Biosciences
Guillain-Barré Syndrome
ANX005
Wave Life Sciences
Praxis Precision Medicines
Novartis, Voyager launch another gene therapy mission with $100M upfront deal
Fierce Biotech
Tue, 01/2/24 - 10:05 am
Novartis
gene therapy
Voyager Therapeutics
Huntington's disease
SMA
Benefit of uniQure's Huntington's gene therapy will be revealed 'in the fullness of time'
Fierce Biotech
Tue, 12/19/23 - 11:14 pm
uniQure
Huntington's disease
gene therapy
Neurocrine Touts Phase III Huntington’s Data, Posts 29% YoY Growth
BioSpace
Fri, 11/3/23 - 11:38 am
Neurocine Biosciences
Huntington's disease
Ingrezza
Roche pays Ionis $60M upfront to license RNA-targeting Alzheimer's, Huntington's programs
Fierce Biotech
Wed, 09/27/23 - 10:14 am
Roche
Ionis Pharmaceuticals
RNA
Alzheimer's disease
Huntington's disease
Look out, Teva. Neurocrine's Ingrezza wins Huntington's disease FDA nod to rival Austedo
Fierce Pharma
Wed, 08/23/23 - 09:48 am
Neurocrine
Ingrezza
FDA
Huntington's disease
Teva Pharmaceutical
FDA Action Alert: Ipsen, Revance, Neurocrine and Regeneron
BioSpace
Mon, 08/14/23 - 11:29 am
FDA
Ipsen
Revance Therapeutics
Neurocrine
Regeneron
palovarotene
fibrodysplasia ossificans progressiva
Daxxify
cervical dystonia
Ingrezza
chorea
Huntington's disease
pozelimab
CHAPLE disease
Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease
BioSpace
Mon, 07/24/23 - 09:57 am
neurodegenerative disease
Alzheimer's disease
Axsome Therapeutics
Eli Lilly
Anavex
TauRx
AB Science
ALS
BrainStorm Cell Therapeutics
Seelos Therapeutics
Parkinson's Disease
AbbVie
Mitsubishi Tanabe Pharma
Annovis
Huntington's disease
Prilenia Therapeutics
Neurocrine
Uniqure’s accelerated approval hopes take a hit
EP Vantage
Thu, 06/22/23 - 10:07 am
uniQure
Huntington's disease
gene therapy
AMT-130
Teva gains FDA approval for once-daily formulation of flagship drug Austedo
Fierce Pharma
Wed, 02/22/23 - 10:09 am
Teva Pharmaceutical
FDA
Austedo
tardive dyskinesia
Huntington's disease

Pages